ATE108333T1 - Herstellung und verwendung von anti- helminthischen wirkstoffen und schutzantigenen. - Google Patents

Herstellung und verwendung von anti- helminthischen wirkstoffen und schutzantigenen.

Info

Publication number
ATE108333T1
ATE108333T1 AT87904927T AT87904927T ATE108333T1 AT E108333 T1 ATE108333 T1 AT E108333T1 AT 87904927 T AT87904927 T AT 87904927T AT 87904927 T AT87904927 T AT 87904927T AT E108333 T1 ATE108333 T1 AT E108333T1
Authority
AT
Austria
Prior art keywords
production
protective antigens
protein
doublet
helminthic agents
Prior art date
Application number
AT87904927T
Other languages
English (en)
Inventor
Edward Albert Munn
Original Assignee
Edward Albert Munn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edward Albert Munn filed Critical Edward Albert Munn
Application granted granted Critical
Publication of ATE108333T1 publication Critical patent/ATE108333T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87904927T 1986-08-07 1987-08-07 Herstellung und verwendung von anti- helminthischen wirkstoffen und schutzantigenen. ATE108333T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619293A GB8619293D0 (en) 1986-08-07 1986-08-07 Anthelmintic agents

Publications (1)

Publication Number Publication Date
ATE108333T1 true ATE108333T1 (de) 1994-07-15

Family

ID=10602375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87904927T ATE108333T1 (de) 1986-08-07 1987-08-07 Herstellung und verwendung von anti- helminthischen wirkstoffen und schutzantigenen.

Country Status (9)

Country Link
US (1) US5415859A (de)
EP (1) EP0309483B1 (de)
JP (2) JP2759652B2 (de)
AT (1) ATE108333T1 (de)
AU (1) AU619725B2 (de)
DE (1) DE3750225T2 (de)
GB (1) GB8619293D0 (de)
NZ (1) NZ221379A (de)
WO (1) WO1988000835A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
US5948644A (en) * 1988-09-26 1999-09-07 Biotechnology Australia Pty Ltd. Polynucleotides encoding excretory/secretory proteins of parasitic nematodes, host cells transformed therewith
US5747046A (en) * 1989-03-17 1998-05-05 Munn; Edward Albert Vaccine containing a protein complex form Haemonchus contortus
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
EP0434909A3 (en) * 1989-09-18 1992-08-19 Synergen, Inc. Anticoagulant and antihelminthic proteins and methods for the production and use of same
GB9209993D0 (en) 1992-05-08 1992-06-24 Munn Edward A Vaccines
ZW8893A1 (en) * 1992-07-21 1994-06-01 Pitman Moore Inc Vaccines
GB9302302D0 (en) * 1993-02-05 1993-03-24 Pitman Moore Inc Process
US5419897A (en) * 1993-04-09 1995-05-30 Buckman Laboratories International, Inc. Ionene polymers as anthelmintics in animals
GB9322702D0 (en) 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines
AU3360797A (en) * 1996-07-04 1998-02-02 Universiteit Utrecht Vaccine against gastro-intestinal nematodes
AUPP929799A0 (en) * 1999-03-18 1999-04-15 Agriculture Victoria Services Pty Ltd A novel molecule
CN100398155C (zh) * 2005-11-23 2008-07-02 南京农业大学 用于预防反刍动物捻转血矛线虫病的dna疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894603A (en) * 1959-09-02 1962-04-26 Allen & Hanburys Ltd Improvements in or relating to vaccines
AU573407B2 (en) * 1984-11-15 1988-06-09 Biotechnology Australia Proprietary Limited Anthelmintic vaccines comprising a nematode species
IL77061A0 (en) * 1984-11-15 1986-04-29 Biotech Australia Pty Ltd Anthelmintic vaccines
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents

Also Published As

Publication number Publication date
JPH09208490A (ja) 1997-08-12
AU7759087A (en) 1988-02-24
EP0309483A1 (de) 1989-04-05
AU619725B2 (en) 1992-02-06
JP2759652B2 (ja) 1998-05-28
NZ221379A (en) 1991-08-27
DE3750225T2 (de) 1994-11-17
DE3750225D1 (de) 1994-08-18
US5415859A (en) 1995-05-16
EP0309483B1 (de) 1994-07-13
JPH02500359A (ja) 1990-02-08
WO1988000835A1 (en) 1988-02-11
GB8619293D0 (en) 1986-09-17

Similar Documents

Publication Publication Date Title
ATE108333T1 (de) Herstellung und verwendung von anti- helminthischen wirkstoffen und schutzantigenen.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE69119278D1 (de) Monoklonaler Antikörper, der mit einer neuen HLA-Determinante auf MHC-Klasse-I-Moleküle reagiert, und Verfahren zur Aktivierung von Lymphozyten
DK371087D0 (da) Mamalialt interleukin-4
ATE92966T1 (de) Herstellung von m-csf.
DE3485267D1 (de) Herstellung von streptokokken-m-protein-immunogenen und molekularen sonden.
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
DK421687A (da) Vektorvirus, der baerer en heterolog dna-sekvens
ATE112802T1 (de) Herstellung von funktionellen menschlichen urokinasepolypeptiden.
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ES2117299T3 (es) Aparato para la inyeccion embrionaria temprana "in ovo".
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
DE3762612D1 (de) Vermiculitformmassen und daraus hergestellte artikel.
IT1223099B (it) Procedimento per l'iniettofusione di materie artificiali termoplastiche
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
DE58909328D1 (de) Immunogen und seine Verwendung zur Gewinnung von Antikörpern gegen HbA1c.
KR890006253A (ko) 가금류내의 E.coli septicaemia에 대한 백신
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
IT8049346A0 (it) Composizione antigene relativo vaccino e procedimento di produzione
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
DE69128095D1 (de) Azelluläre impfstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee